Involvement of RAGE in radiation-induced acquisition of malignant phenotypes in human glioblastoma cells
Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the...
Uloženo v:
| Vydáno v: | Biochimica et biophysica acta. General subjects Ročník 1868; číslo 9; s. 130650 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
Elsevier B.V
01.09.2024
|
| Témata: | |
| ISSN: | 0304-4165, 1872-8006, 1872-8006 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the mechanism of cell migration enhancement in order to prevent recurrence of GBM. The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor activated by high mobility group box 1 (HMGB1). In this study, we found that RAGE plays a role in the enhancement of cell migration by γ-irradiation in human GBM A172 cells. γ-Irradiation induced actin remodeling, a marker of motility acquisition, and enhancement of cell migration in A172 cells. Both phenotypes were suppressed by specific inhibitors of RAGE (FPS-ZM1 and TTP488) or by knockdown of RAGE. The HMGB1 inhibitor ethyl pyruvate similarly suppressed γ-irradiation-induced enhancement of cell migration. In addition, γ-irradiation-induced phosphorylation of STAT3 was suppressed by RAGE inhibitors, and a STAT3 inhibitor suppressed γ-irradiation-induced enhancement of cell migration, indicating that STAT3 is involved in the migration enhancement downstream of RAGE. Our results suggest that HMGB1-RAGE-STAT3 signaling is involved in radiation-induced enhancement of GBM cell migration, and may contribute to GBM recurrence by promoting metastasis and invasion.
[Display omitted]
•γ-Radiation induces enhanced migration of human glioblastoma cells.•RAGE and RAGE ligands are involved in radiation-induced cell migration.•STAT3 signaling is involved in radiation-induced cell migration.•Radiation-induced phosphorylation of STAT3 is mediated by RAGE.•HMGB1-RAGE-STAT3 signaling is involved in radiation-enhanced cell migration. |
|---|---|
| AbstractList | Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the mechanism of cell migration enhancement in order to prevent recurrence of GBM. The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor activated by high mobility group box 1 (HMGB1). In this study, we found that RAGE plays a role in the enhancement of cell migration by γ-irradiation in human GBM A172 cells. γ-Irradiation induced actin remodeling, a marker of motility acquisition, and enhancement of cell migration in A172 cells. Both phenotypes were suppressed by specific inhibitors of RAGE (FPS-ZM1 and TTP488) or by knockdown of RAGE. The HMGB1 inhibitor ethyl pyruvate similarly suppressed γ-irradiation-induced enhancement of cell migration. In addition, γ-irradiation-induced phosphorylation of STAT3 was suppressed by RAGE inhibitors, and a STAT3 inhibitor suppressed γ-irradiation-induced enhancement of cell migration, indicating that STAT3 is involved in the migration enhancement downstream of RAGE. Our results suggest that HMGB1-RAGE-STAT3 signaling is involved in radiation-induced enhancement of GBM cell migration, and may contribute to GBM recurrence by promoting metastasis and invasion. Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the mechanism of cell migration enhancement in order to prevent recurrence of GBM. The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor activated by high mobility group box 1 (HMGB1). In this study, we found that RAGE plays a role in the enhancement of cell migration by γ-irradiation in human GBM A172 cells. γ-Irradiation induced actin remodeling, a marker of motility acquisition, and enhancement of cell migration in A172 cells. Both phenotypes were suppressed by specific inhibitors of RAGE (FPS-ZM1 and TTP488) or by knockdown of RAGE. The HMGB1 inhibitor ethyl pyruvate similarly suppressed γ-irradiation-induced enhancement of cell migration. In addition, γ-irradiation-induced phosphorylation of STAT3 was suppressed by RAGE inhibitors, and a STAT3 inhibitor suppressed γ-irradiation-induced enhancement of cell migration, indicating that STAT3 is involved in the migration enhancement downstream of RAGE. Our results suggest that HMGB1-RAGE-STAT3 signaling is involved in radiation-induced enhancement of GBM cell migration, and may contribute to GBM recurrence by promoting metastasis and invasion. [Display omitted] •γ-Radiation induces enhanced migration of human glioblastoma cells.•RAGE and RAGE ligands are involved in radiation-induced cell migration.•STAT3 signaling is involved in radiation-induced cell migration.•Radiation-induced phosphorylation of STAT3 is mediated by RAGE.•HMGB1-RAGE-STAT3 signaling is involved in radiation-enhanced cell migration. Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the mechanism of cell migration enhancement in order to prevent recurrence of GBM. The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor activated by high mobility group box 1 (HMGB1). In this study, we found that RAGE plays a role in the enhancement of cell migration by γ-irradiation in human GBM A172 cells. γ-Irradiation induced actin remodeling, a marker of motility acquisition, and enhancement of cell migration in A172 cells. Both phenotypes were suppressed by specific inhibitors of RAGE (FPS-ZM1 and TTP488) or by knockdown of RAGE. The HMGB1 inhibitor ethyl pyruvate similarly suppressed γ-irradiation-induced enhancement of cell migration. In addition, γ-irradiation-induced phosphorylation of STAT3 was suppressed by RAGE inhibitors, and a STAT3 inhibitor suppressed γ-irradiation-induced enhancement of cell migration, indicating that STAT3 is involved in the migration enhancement downstream of RAGE. Our results suggest that HMGB1-RAGE-STAT3 signaling is involved in radiation-induced enhancement of GBM cell migration, and may contribute to GBM recurrence by promoting metastasis and invasion.Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead to the acquisition of migration ability by cancer cells, thereby promoting tumor metastasis and invasion, it is important to understand the mechanism of cell migration enhancement in order to prevent recurrence of GBM. The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor activated by high mobility group box 1 (HMGB1). In this study, we found that RAGE plays a role in the enhancement of cell migration by γ-irradiation in human GBM A172 cells. γ-Irradiation induced actin remodeling, a marker of motility acquisition, and enhancement of cell migration in A172 cells. Both phenotypes were suppressed by specific inhibitors of RAGE (FPS-ZM1 and TTP488) or by knockdown of RAGE. The HMGB1 inhibitor ethyl pyruvate similarly suppressed γ-irradiation-induced enhancement of cell migration. In addition, γ-irradiation-induced phosphorylation of STAT3 was suppressed by RAGE inhibitors, and a STAT3 inhibitor suppressed γ-irradiation-induced enhancement of cell migration, indicating that STAT3 is involved in the migration enhancement downstream of RAGE. Our results suggest that HMGB1-RAGE-STAT3 signaling is involved in radiation-induced enhancement of GBM cell migration, and may contribute to GBM recurrence by promoting metastasis and invasion. |
| ArticleNumber | 130650 |
| Author | Tanuma, Sei-ichi Tsukimoto, Mitsutoshi Kitabatake, Kazuki Seki, Hiromu |
| Author_xml | – sequence: 1 givenname: Hiromu surname: Seki fullname: Seki, Hiromu organization: Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan – sequence: 2 givenname: Kazuki surname: Kitabatake fullname: Kitabatake, Kazuki organization: Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan – sequence: 3 givenname: Sei-ichi surname: Tanuma fullname: Tanuma, Sei-ichi organization: Meikai University Research Institute of Odontology, Sakado, Saitama, Japan – sequence: 4 givenname: Mitsutoshi surname: Tsukimoto fullname: Tsukimoto, Mitsutoshi email: tsukim@rs.noda.tus.ac.jp organization: Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38830560$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU9r3DAQxUVIaTZJv0EoPvbi7eiv5UshhDQNBAqlOQtZGu9qsaWNZS_k28fGaY_tXAZmfm8Y3rsk5zFFJOSGwpYCVV8P26axO4xbBkxsKQcl4YxsqK5YqQHUOdkAB1EKquQFucz5AHPJWn4kF1xrDlLBhuwf4yl1J-wxjkVqi1-3D_dFiMVgfbBjSLEM0U8OfWHdyxRyWGYL2Nsu7KKdVcc9xjS-HjEvwv3U21jsupCazuYx9bZw2HX5mnxobZfx03u_Is_f73_f_Siffj483t0-lY7XMJasqaVonfMKBPMtbaXG2jmGjnmnWN0oJix32tUoVSUrX6vKUyr0vEcvKL8iX9a7xyG9TJhH04e8fGAjpikbzgCYrkDA_1FQQmpKFZ_Rz-_o1PTozXEIvR1ezR8jZ0CsgBtSzgO2fxEKZsnLHMyal1nyMmtes-zbKsPZklPAwWQXMM5-hwHdaHwK_z7wBvedn5s |
| Cites_doi | 10.1002/mc.22944 10.3390/molecules26216741 10.7150/thno.30578 10.1186/s13014-021-01767-9 10.1074/jbc.M801465200 10.1248/bpb.b20-00654 10.1155/2020/8833885 10.1186/s40425-019-0765-z 10.1016/j.cancergen.2012.10.009 10.1248/bpb.b23-00631 10.1038/s41419-020-2432-1 10.1007/s10549-013-2737-1 10.1038/s12276-022-00736-w 10.1248/bpbreports.3.1_50 10.1007/978-3-030-30651-9_10 10.3390/cancers10110456 10.3349/ymj.2019.60.1.38 10.1038/nature13111 10.1007/164_2016_28 10.1007/s12672-022-00527-9 10.3389/fimmu.2022.931473 10.1016/j.pharmthera.2022.108118 10.1038/s41523-023-00564-9 10.3390/molecules14041561 10.1091/mbc.e11-02-0119 10.3892/etm.2014.2089 10.1146/annurev.immunol.021908.132603 10.1242/jcs.218222 10.1007/s11684-020-0760-2 10.1101/gad.891601 10.1038/nature05236 10.1186/s12957-022-02500-w |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s) Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2024 The Author(s) – notice: Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| DOI | 10.1016/j.bbagen.2024.130650 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1872-8006 |
| ExternalDocumentID | 38830560 10_1016_j_bbagen_2024_130650 S030441652400093X |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAFTH AAHBH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABGSF ABMAC ABUDA ABXDB ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- 9DU AATTM AAXKI AAYWO AAYXX ABFNM ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKYEP ANKPU APXCP CITATION EFKBS EFLBG ~HD AGCQF AGRNS BNPGV CGR CUY CVF ECM EIF NPM SSH 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c390t-2b954fccd6042df1f58e9cc2ec2dc629b624a3c8c9e56757d967d1148c2ded413 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001257737000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0304-4165 1872-8006 |
| IngestDate | Thu Oct 02 22:47:19 EDT 2025 Sat Sep 27 16:32:38 EDT 2025 Mon Jul 21 05:41:19 EDT 2025 Sat Nov 29 01:38:15 EST 2025 Sat Jul 27 15:40:32 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | RAGE HMGB1 Cell migration Glioblastoma Radiation STAT3 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c390t-2b954fccd6042df1f58e9cc2ec2dc629b624a3c8c9e56757d967d1148c2ded413 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.bbagen.2024.130650 |
| PMID | 38830560 |
| PQID | 3064581163 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3200287040 proquest_miscellaneous_3064581163 pubmed_primary_38830560 crossref_primary_10_1016_j_bbagen_2024_130650 elsevier_sciencedirect_doi_10_1016_j_bbagen_2024_130650 |
| PublicationCentury | 2000 |
| PublicationDate | September 2024 2024-09-00 20240901 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: September 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Biochimica et biophysica acta. General subjects |
| PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
| PublicationYear | 2024 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Maher, Furnari, Bachoo (bb0010) 2001; 15 Healey, Pan-Castillo, Garcia-Parra, Davies, Roberts, Jones, Dhar, Nandanan, Tofazzal, Piggott, Clarkson, Seaton, Frostell, Fagge, McKee, Margarit, Conlan, Gonzalez (bb0065) 2019; 7 Swiatek-Machado, Kaminska (bb0180) 2020; 1202 Oyama, Sakamoto, Kitabatake, Shiina, Kitahara, Onozawa, Nishino, Sudo, Tsukimoto (bb0050) 2024; 47 Zhang, Shao, Han, Xu, Jiao, Wu, Yang, Ge, Shi, Li, Wen, Qin (bb0155) 2018; 53 Chen, Lyu, Chen, Lee, Pan, Ho, Wang (bb0095) 2021; 26 Dong, Zhang, Huang, Deng (bb0020) 2022; 13 Bao, Wu, McLendon, Hao, Shi, Hjelmeland, Dewhirst, Bigner, Rich (bb0100) 2006; 444 Wang, Zhou, Fu, Zhang, Liang, Shou, Wang, Ma (bb0140) 2015; 9 Bao, Wang, Wang, Fang, Shan, Wang, Jiang (bb0110) 2021; 15 Xu, Zhang, Li, Gao, Pei, Cao, He (bb0130) 2019; 60 Zhang, Zheng, Li, Zhu (bb0160) 2022; 20 Qian, Xiao, Gai, Zhu (bb0030) 2019; 58 Minniti, Niyazi, Alongi, Navarria, Belka (bb0115) 2021; 16 Magna, Hwang, McIntosh, Drews-Elger, Takabatake, Ikeda, Mera, Kwak, Miller, Lippman, Hudson (bb0040) 2023; 9 Sims, Rowe, Rietdijk, Herbst, Coyle (bb0025) 2010; 28 Wank, Schilling, Schmid, Meyer, Gempt, Barz, Schlegel, Liesche, Kessel, Wiestler, Bette, Zimmer, Combs (bb0015) 2018; 10 Washiya, Sasaki, Nakanishi, Kitabatake, Nishino, Tanuma, Kojima, Tsukimoto (bb0055) 2020; 3 Zhu, Ren, Daniels, Qiu, Song, You, Wang, Wang (bb0075) 2021 Kitabatake, Kaji, Tsukimoto (bb0045) 2021; 44 Bald, Quast, Landsberg, Rogava, Glodde, Lopez-Ramos, Kohlmeyer, Riesenberg, van den Boorn-Konijnenberg, Hömig-Hölzel, Reuten, Schadow, Weighardt, Wenzel, Helfrich, Schadendorf, Bloch, Bianchi, Lugassy, Barnhill, Koch, Fleischmann, Förster, Kastenmüller, Kolanus, Hölzel, Gaffal, Tüting (bb0150) 2014; 507 Shih (bb0090) 2022; 234 Hudson, Kalea, Del Mar, Harja, Boulanger, D’Agati, Schmidt (bb0125) 2008; 283 Koukourakis, Kouloulias, Zacharias, Papadimitriou, Pantelakos, Maravelis, Fotineas, Beli, Chaldeopoulos, Kouvaris (bb0105) 2009; 14 Lehtimäki, Hakala, Lappalainen (bb0080) 2017; 235 Li, Beeraka, Xie, Dong, Liu, Wang (bb0060) 2022; 13 Wang, He, Bao, He, Fan, Wang (bb0070) 2016; 40 Gau, Roy (bb0120) 2018; 131 Qie, Wang, Chu, Wang (bb0035) 2015; 8 Li, Li, Zhang, Da, Chen, Yu, Zhou, Weng, Xin, Shi, Ma, Huang, Qi, Lu (bb0165) 2019; 9 Yin, Li, Zhang, Liu, Lu, Lu, Sun, Qi, Li, Chen (bb0170) 2013; 142 Haynes, Srivastava, Madson, Wittmann, Barber (bb0085) 2011; 22 Chen, Chen, Chang, Lin, Wu, Kao, Teng, Hsu, Yang (bb0135) 2020; 11 Liang, Li, Gong, Wang, Lu, Zhao, Gu (bb0175) 2020; 2020 Chen, Kang, Tang (bb0145) 2022; 54 Goodenberger, Jenkins (bb0005) 2012; 205 Goodenberger (10.1016/j.bbagen.2024.130650_bb0005) 2012; 205 Swiatek-Machado (10.1016/j.bbagen.2024.130650_bb0180) 2020; 1202 Xu (10.1016/j.bbagen.2024.130650_bb0130) 2019; 60 Bald (10.1016/j.bbagen.2024.130650_bb0150) 2014; 507 Liang (10.1016/j.bbagen.2024.130650_bb0175) 2020; 2020 Qian (10.1016/j.bbagen.2024.130650_bb0030) 2019; 58 Li (10.1016/j.bbagen.2024.130650_bb0165) 2019; 9 Gau (10.1016/j.bbagen.2024.130650_bb0120) 2018; 131 Kitabatake (10.1016/j.bbagen.2024.130650_bb0045) 2021; 44 Minniti (10.1016/j.bbagen.2024.130650_bb0115) 2021; 16 Magna (10.1016/j.bbagen.2024.130650_bb0040) 2023; 9 Wang (10.1016/j.bbagen.2024.130650_bb0070) 2016; 40 Zhang (10.1016/j.bbagen.2024.130650_bb0155) 2018; 53 Lehtimäki (10.1016/j.bbagen.2024.130650_bb0080) 2017; 235 Maher (10.1016/j.bbagen.2024.130650_bb0010) 2001; 15 Chen (10.1016/j.bbagen.2024.130650_bb0095) 2021; 26 Bao (10.1016/j.bbagen.2024.130650_bb0100) 2006; 444 Dong (10.1016/j.bbagen.2024.130650_bb0020) 2022; 13 Wank (10.1016/j.bbagen.2024.130650_bb0015) 2018; 10 Zhu (10.1016/j.bbagen.2024.130650_bb0075) 2021 Haynes (10.1016/j.bbagen.2024.130650_bb0085) 2011; 22 Sims (10.1016/j.bbagen.2024.130650_bb0025) 2010; 28 Koukourakis (10.1016/j.bbagen.2024.130650_bb0105) 2009; 14 Bao (10.1016/j.bbagen.2024.130650_bb0110) 2021; 15 Li (10.1016/j.bbagen.2024.130650_bb0060) 2022; 13 Chen (10.1016/j.bbagen.2024.130650_bb0135) 2020; 11 Washiya (10.1016/j.bbagen.2024.130650_bb0055) 2020; 3 Healey (10.1016/j.bbagen.2024.130650_bb0065) 2019; 7 Hudson (10.1016/j.bbagen.2024.130650_bb0125) 2008; 283 Shih (10.1016/j.bbagen.2024.130650_bb0090) 2022; 234 Zhang (10.1016/j.bbagen.2024.130650_bb0160) 2022; 20 Yin (10.1016/j.bbagen.2024.130650_bb0170) 2013; 142 Chen (10.1016/j.bbagen.2024.130650_bb0145) 2022; 54 Wang (10.1016/j.bbagen.2024.130650_bb0140) 2015; 9 Qie (10.1016/j.bbagen.2024.130650_bb0035) 2015; 8 Oyama (10.1016/j.bbagen.2024.130650_bb0050) 2024; 47 |
| References_xml | – volume: 26 start-page: 6741 year: 2021 ident: bb0095 article-title: Chloroquine potentiates the anticancer effect of Pterostilbene on pancreatic cancer by inhibiting autophagy and downregulating the RAGE/STAT3 pathway publication-title: Molecules – volume: 58 start-page: 500 year: 2019 end-page: 510 ident: bb0030 article-title: HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development publication-title: Mol. Carcinog. – volume: 15 start-page: 1311 year: 2001 end-page: 1333 ident: bb0010 article-title: Malignant glioma: genetics and biology of a grave matter publication-title: Genes Dev. – volume: 40 start-page: 91 year: 2016 end-page: 99 ident: bb0070 article-title: Ionizing radiation induces HMGB1 cytoplasmic translocation and extracellular release publication-title: Guo Ji Fang She Yi Xue He Yi Xue Za Zhi. – volume: 235 start-page: 123 year: 2017 end-page: 152 ident: bb0080 article-title: Actin filament structures in migrating cells publication-title: Handb. Exp. Pharmacol. – volume: 22 start-page: 4750 year: 2011 end-page: 4764 ident: bb0085 article-title: Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression publication-title: Mol. Biol. Cell – volume: 13 start-page: 64 year: 2022 ident: bb0060 article-title: Co-expression of high-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma publication-title: Discov. Oncol. – volume: 234 year: 2022 ident: bb0090 article-title: The role of the STAT3 signaling transduction pathways in radioresistance publication-title: Pharmacol. Ther. – volume: 9 start-page: 59 year: 2023 ident: bb0040 article-title: RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer publication-title: NPJ Breast Cancer. – volume: 60 start-page: 38 year: 2019 end-page: 47 ident: bb0130 article-title: Up-regulation of MiR-1915 inhibits proliferation, invasion, and migration of publication-title: Yonsei Med. J. – volume: 2020 year: 2020 ident: bb0175 article-title: Clinicopathological and prognostic roles of STAT3 and its phosphorylation in glioma publication-title: Dis. Markers – volume: 7 start-page: 280 year: 2019 ident: bb0065 article-title: Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer publication-title: J. Immunother. Cancer – volume: 11 start-page: 265 year: 2020 ident: bb0135 article-title: RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer publication-title: Cell Death Dis. – volume: 1202 start-page: 203 year: 2020 end-page: 222 ident: bb0180 article-title: STAT Signaling in Glioma Cells publication-title: Adv. Exp. Med. Biol. – volume: 14 start-page: 1561 year: 2009 end-page: 1577 ident: bb0105 article-title: Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article publication-title: Molecules – volume: 8 start-page: 6262 year: 2015 end-page: 6268 ident: bb0035 article-title: Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance publication-title: Int. J. Clin. Exp. Pathol. – volume: 9 start-page: 513 year: 2015 end-page: 518 ident: bb0140 article-title: Clinical and prognostic significance of high-mobility group box-1 in human gliomas publication-title: Exp. Ther. Med. – volume: 13 year: 2022 ident: bb0020 article-title: Pathophysiology of RAGE in inflammatory diseases publication-title: Front. Immunol. – volume: 54 start-page: 91 year: 2022 end-page: 102 ident: bb0145 article-title: The mechanism of HMGB1 secretion and release publication-title: Exp. Mol. Med. – volume: 142 start-page: 297 year: 2013 end-page: 309 ident: bb0170 article-title: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition publication-title: Breast Cancer Res. Treat. – volume: 28 start-page: 367 year: 2010 end-page: 388 ident: bb0025 article-title: HMGB1 and RAGE in inflammation and cancer publication-title: Annu. Rev. Immunol. – volume: 205 start-page: 613 year: 2012 end-page: 621 ident: bb0005 article-title: Genetics of adult glioma publication-title: Cancer Gene Ther. – volume: 283 start-page: 34457 year: 2008 end-page: 34468 ident: bb0125 article-title: Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 publication-title: J. Biol. Chem. – volume: 20 start-page: 101 year: 2022 ident: bb0160 article-title: miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer publication-title: World J. Surg. Oncol. – volume: 10 start-page: 456 year: 2018 ident: bb0015 article-title: Human glioma migration and infiltration properties as a target for personalized radiation medicine publication-title: Cancers (Basel) – volume: 444 start-page: 756 year: 2006 end-page: 760 ident: bb0100 article-title: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response publication-title: Nature – volume: 15 start-page: 551 year: 2021 end-page: 561 ident: bb0110 article-title: Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution publication-title: Front. Med. – volume: 3 start-page: 50 year: 2020 end-page: 55 ident: bb0055 article-title: Involvement of TRPV1 and TRPV4 channels in enhancement of metastatic ability induced by γ-irradiation in human lung cancer A549 cells publication-title: BPB Reports – volume: 53 start-page: 659 year: 2018 end-page: 671 ident: bb0155 article-title: High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway publication-title: Int. J. Oncol. – year: 2021 ident: bb0075 article-title: Exogenous HMGB1 promotes the proliferation and metastasis of pancreatic cancer cells publication-title: Front. Med. (Lausanne). – volume: 131 year: 2018 ident: bb0120 article-title: SRF’ing and SAP’ing - the role of MRTF proteins in cell migration publication-title: J. Cell Sci. – volume: 16 start-page: 36 year: 2021 ident: bb0115 article-title: Current status and recent advances in reirradiation of glioblastoma publication-title: Radiat. Oncol. – volume: 47 start-page: 60 year: 2024 end-page: 71 ident: bb0050 article-title: Involvement of cannabinoid receptors and adenosine A2B receptor in enhanced migration of lung Cancer A549 cells induced by γ-ray irradiation publication-title: Biol. Pharm. Bull. – volume: 507 start-page: 109 year: 2014 end-page: 113 ident: bb0150 article-title: Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma publication-title: Nature – volume: 9 start-page: 1909 year: 2019 end-page: 1922 ident: bb0165 article-title: HMGB1-induced p62 overexpression promotes snail-mediated epithelial-mesenchymal transition in glioblastoma cells via the degradation of GSK-3β publication-title: Theranostics – volume: 44 start-page: 197 year: 2021 end-page: 210 ident: bb0045 article-title: Involvement of CD73 and A2B receptor in radiation-induced DNA damage response and cell migration in human glioblastoma A172 cells publication-title: Biol. Pharm. Bull. – volume: 58 start-page: 500 issue: 4 year: 2019 ident: 10.1016/j.bbagen.2024.130650_bb0030 article-title: HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development publication-title: Mol. Carcinog. doi: 10.1002/mc.22944 – volume: 26 start-page: 6741 issue: 21 year: 2021 ident: 10.1016/j.bbagen.2024.130650_bb0095 article-title: Chloroquine potentiates the anticancer effect of Pterostilbene on pancreatic cancer by inhibiting autophagy and downregulating the RAGE/STAT3 pathway publication-title: Molecules doi: 10.3390/molecules26216741 – volume: 9 start-page: 1909 issue: 7 year: 2019 ident: 10.1016/j.bbagen.2024.130650_bb0165 article-title: HMGB1-induced p62 overexpression promotes snail-mediated epithelial-mesenchymal transition in glioblastoma cells via the degradation of GSK-3β publication-title: Theranostics doi: 10.7150/thno.30578 – volume: 53 start-page: 659 issue: 2 year: 2018 ident: 10.1016/j.bbagen.2024.130650_bb0155 article-title: High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway publication-title: Int. J. Oncol. – volume: 16 start-page: 36 issue: 1 year: 2021 ident: 10.1016/j.bbagen.2024.130650_bb0115 article-title: Current status and recent advances in reirradiation of glioblastoma publication-title: Radiat. Oncol. doi: 10.1186/s13014-021-01767-9 – volume: 283 start-page: 34457 issue: 49 year: 2008 ident: 10.1016/j.bbagen.2024.130650_bb0125 article-title: Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M801465200 – volume: 44 start-page: 197 issue: 2 year: 2021 ident: 10.1016/j.bbagen.2024.130650_bb0045 article-title: Involvement of CD73 and A2B receptor in radiation-induced DNA damage response and cell migration in human glioblastoma A172 cells publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b20-00654 – volume: 2020 year: 2020 ident: 10.1016/j.bbagen.2024.130650_bb0175 article-title: Clinicopathological and prognostic roles of STAT3 and its phosphorylation in glioma publication-title: Dis. Markers doi: 10.1155/2020/8833885 – volume: 7 start-page: 280 issue: 1 year: 2019 ident: 10.1016/j.bbagen.2024.130650_bb0065 article-title: Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer publication-title: J. Immunother. Cancer doi: 10.1186/s40425-019-0765-z – volume: 205 start-page: 613 issue: 12 year: 2012 ident: 10.1016/j.bbagen.2024.130650_bb0005 article-title: Genetics of adult glioma publication-title: Cancer Gene Ther. doi: 10.1016/j.cancergen.2012.10.009 – volume: 47 start-page: 60 issue: 1 year: 2024 ident: 10.1016/j.bbagen.2024.130650_bb0050 article-title: Involvement of cannabinoid receptors and adenosine A2B receptor in enhanced migration of lung Cancer A549 cells induced by γ-ray irradiation publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b23-00631 – volume: 11 start-page: 265 issue: 4 year: 2020 ident: 10.1016/j.bbagen.2024.130650_bb0135 article-title: RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer publication-title: Cell Death Dis. doi: 10.1038/s41419-020-2432-1 – volume: 142 start-page: 297 issue: 2 year: 2013 ident: 10.1016/j.bbagen.2024.130650_bb0170 article-title: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-013-2737-1 – volume: 54 start-page: 91 issue: 2 year: 2022 ident: 10.1016/j.bbagen.2024.130650_bb0145 article-title: The mechanism of HMGB1 secretion and release publication-title: Exp. Mol. Med. doi: 10.1038/s12276-022-00736-w – volume: 3 start-page: 50 year: 2020 ident: 10.1016/j.bbagen.2024.130650_bb0055 article-title: Involvement of TRPV1 and TRPV4 channels in enhancement of metastatic ability induced by γ-irradiation in human lung cancer A549 cells publication-title: BPB Reports doi: 10.1248/bpbreports.3.1_50 – volume: 1202 start-page: 203 year: 2020 ident: 10.1016/j.bbagen.2024.130650_bb0180 article-title: STAT Signaling in Glioma Cells publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-3-030-30651-9_10 – volume: 40 start-page: 91 issue: 2 year: 2016 ident: 10.1016/j.bbagen.2024.130650_bb0070 article-title: Ionizing radiation induces HMGB1 cytoplasmic translocation and extracellular release publication-title: Guo Ji Fang She Yi Xue He Yi Xue Za Zhi. – volume: 10 start-page: 456 issue: 11 year: 2018 ident: 10.1016/j.bbagen.2024.130650_bb0015 article-title: Human glioma migration and infiltration properties as a target for personalized radiation medicine publication-title: Cancers (Basel) doi: 10.3390/cancers10110456 – volume: 60 start-page: 38 issue: 1 year: 2019 ident: 10.1016/j.bbagen.2024.130650_bb0130 article-title: Up-regulation of MiR-1915 inhibits proliferation, invasion, and migration of helicobacter pylori-infected gastric cancer cells via targeting RAGE publication-title: Yonsei Med. J. doi: 10.3349/ymj.2019.60.1.38 – volume: 507 start-page: 109 issue: 7490 year: 2014 ident: 10.1016/j.bbagen.2024.130650_bb0150 article-title: Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma publication-title: Nature doi: 10.1038/nature13111 – volume: 235 start-page: 123 year: 2017 ident: 10.1016/j.bbagen.2024.130650_bb0080 article-title: Actin filament structures in migrating cells publication-title: Handb. Exp. Pharmacol. doi: 10.1007/164_2016_28 – volume: 13 start-page: 64 issue: 1 year: 2022 ident: 10.1016/j.bbagen.2024.130650_bb0060 article-title: Co-expression of high-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma publication-title: Discov. Oncol. doi: 10.1007/s12672-022-00527-9 – volume: 13 year: 2022 ident: 10.1016/j.bbagen.2024.130650_bb0020 article-title: Pathophysiology of RAGE in inflammatory diseases publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.931473 – volume: 234 year: 2022 ident: 10.1016/j.bbagen.2024.130650_bb0090 article-title: The role of the STAT3 signaling transduction pathways in radioresistance publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2022.108118 – volume: 9 start-page: 59 issue: 1 year: 2023 ident: 10.1016/j.bbagen.2024.130650_bb0040 article-title: RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer publication-title: NPJ Breast Cancer. doi: 10.1038/s41523-023-00564-9 – volume: 14 start-page: 1561 issue: 4 year: 2009 ident: 10.1016/j.bbagen.2024.130650_bb0105 article-title: Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article publication-title: Molecules doi: 10.3390/molecules14041561 – volume: 8 start-page: 6262 issue: 6 year: 2015 ident: 10.1016/j.bbagen.2024.130650_bb0035 article-title: Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance publication-title: Int. J. Clin. Exp. Pathol. – volume: 22 start-page: 4750 issue: 24 year: 2011 ident: 10.1016/j.bbagen.2024.130650_bb0085 article-title: Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression publication-title: Mol. Biol. Cell doi: 10.1091/mbc.e11-02-0119 – volume: 9 start-page: 513 issue: 2 year: 2015 ident: 10.1016/j.bbagen.2024.130650_bb0140 article-title: Clinical and prognostic significance of high-mobility group box-1 in human gliomas publication-title: Exp. Ther. Med. doi: 10.3892/etm.2014.2089 – volume: 28 start-page: 367 year: 2010 ident: 10.1016/j.bbagen.2024.130650_bb0025 article-title: HMGB1 and RAGE in inflammation and cancer publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.021908.132603 – volume: 131 issue: 19 year: 2018 ident: 10.1016/j.bbagen.2024.130650_bb0120 article-title: SRF’ing and SAP’ing - the role of MRTF proteins in cell migration publication-title: J. Cell Sci. doi: 10.1242/jcs.218222 – volume: 15 start-page: 551 issue: 4 year: 2021 ident: 10.1016/j.bbagen.2024.130650_bb0110 article-title: Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution publication-title: Front. Med. doi: 10.1007/s11684-020-0760-2 – volume: 15 start-page: 1311 issue: 11 year: 2001 ident: 10.1016/j.bbagen.2024.130650_bb0010 article-title: Malignant glioma: genetics and biology of a grave matter publication-title: Genes Dev. doi: 10.1101/gad.891601 – issue: 8 year: 2021 ident: 10.1016/j.bbagen.2024.130650_bb0075 article-title: Exogenous HMGB1 promotes the proliferation and metastasis of pancreatic cancer cells publication-title: Front. Med. (Lausanne). – volume: 444 start-page: 756 issue: 7120 year: 2006 ident: 10.1016/j.bbagen.2024.130650_bb0100 article-title: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response publication-title: Nature doi: 10.1038/nature05236 – volume: 20 start-page: 101 issue: 1 year: 2022 ident: 10.1016/j.bbagen.2024.130650_bb0160 article-title: miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer publication-title: World J. Surg. Oncol. doi: 10.1186/s12957-022-02500-w |
| SSID | ssj0000595 |
| Score | 2.4592373 |
| Snippet | Glioblastoma (GBM), a highly aggressive malignant tumor of the central nervous system, is mainly treated with radiotherapy. However, since irradiation may lead... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 130650 |
| SubjectTerms | actin Benzamides Brain Neoplasms - metabolism Brain Neoplasms - pathology Brain Neoplasms - radiotherapy Cell Line, Tumor Cell migration cell movement Cell Movement - radiation effects central nervous system Gamma Rays Glioblastoma Glioblastoma - metabolism Glioblastoma - pathology Glioblastoma - radiotherapy HMGB1 HMGB1 Protein - metabolism Humans irradiation metastasis nucleoproteins Phenotype phosphorylation Phosphorylation - radiation effects Pyruvates - pharmacology pyruvic acid Radiation radiotherapy RAGE Receptor for Advanced Glycation End Products - metabolism Signal Transduction STAT3 STAT3 Transcription Factor - metabolism |
| Title | Involvement of RAGE in radiation-induced acquisition of malignant phenotypes in human glioblastoma cells |
| URI | https://dx.doi.org/10.1016/j.bbagen.2024.130650 https://www.ncbi.nlm.nih.gov/pubmed/38830560 https://www.proquest.com/docview/3064581163 https://www.proquest.com/docview/3200287040 |
| Volume | 1868 |
| WOSCitedRecordID | wos001257737000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1872-8006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: AIEXJ dateStart: 19950118 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DgQvCMZtXKYgIV4iT0mai_04TZ0YVANBJ_Utsh1ny9iSrkmmwZ_hr3JOnKSdxmA88BJV8SWJz1f73A8hb6XypcbIXK7dkPoi9KiMXE4DEbmJ56Yq1E12_Ul0cMBmM_55MPjZxcJcnEZ5zi4v-fy_khruAbExdPYfyN1PCjfgNxAdrkB2uN6K8Ps57DhNFvDGyP8FTUYYtIJJCPCpFKTwGq3-Qp3XmXHZaqzswJEfoVuMjW5fBepmG19ZU8Xv6DQrJHDaVXEmbNT2l1fMwVmhjjPMPGDrypZZYRQmAlN1iO0ut7Vd1hLVPj0b_1W3RbOzRXFWL90BKiFFJYzb0Efxo_6WLRUMObxOo7LVGc3goX1LCd0Ad4UJBqjKuirKtrnVanh-77bVR3M5PgVmMbi6U4dsBZPcnmMxa-Ax6W8PA6OXONmWErZmzHXr-W3_5eHXGfwPPsV7h5NJPB3Ppu_m5xTLkqH5vq3RskbWvSjgbEjWd_bHsw_Lwz5oCvv0r9tFZzYuhNcffBP3c5N003A504fkQSueWDsGVo_IQOcb5K4pWPp9g9zb7eoDPibHK0CzitRCoFlZbl0DmrUCNOzYA81aAg0HNkCzVoFmNUB7Qg73xtPd97St20HViDsV9SQP_FSpJIQTIUndNGCaK-Vp5SUq9LgMPV-MFFNcByCvRgkPowTlcmjXCXBVT8kwL3L9nFjBCKZxQzhWJQjKwpGayZQ5kqV85LrS2SS0W894btKzxJ3f4kls1j_G9Y_N-m-SqFv0uGUxDesYA2j-MvJNR6MYFhq_X-S6qMsYZfiAuSDY_KEP-kLB0ejDPM8Mgfv3HTGGcrzz4hajX5L7y3_LKzKsFrV-Te6oiyorF1tkLZqxrRaivwDnG8Jo |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+RAGE+in+radiation-induced+acquisition+of+malignant+phenotypes+in+human+glioblastoma+cells&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Seki%2C+Hiromu&rft.au=Kitabatake%2C+Kazuki&rft.au=Tanuma%2C+Sei-ichi&rft.au=Tsukimoto%2C+Mitsutoshi&rft.date=2024-09-01&rft.issn=0304-4165&rft.volume=1868&rft.issue=9+p.130650-&rft_id=info:doi/10.1016%2Fj.bbagen.2024.130650&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |